With 55 years of clinical and translational research experience, EORTC has built a database referring to more than 195,000 patients. So EORTC is in a unique position to further analyse this wealth of information to gain a broader understanding of cancer and its mechanisms.
This prospective research focuses on, among other things:
- Identifying the predictive value of certain biomarkers
- Meta-analysis of data to detect variations within subgroups of patients
- The development and analysis of prognostic factors
- Long-term survivorship and quality of life analysis
- Monitoring of side effects
This research aims to advance the collective knowledge base in oncology and accelerate further developments that may lead to improved treatments. As an academic, independent organisation, EORTC is ideally positioned to conduct these essential public health research projects.